cytidine diphosphate choline has been researched along with Cognitive Dysfunction in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 10 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Nemkova, SA; Petrova, EA; Semenov, DV; Vozvyshaeva, MY; Zavadenko, NN | 1 |
| Gavrilova, SI; Ponomareva, EV; Roshchina, IF; Selezneva, ND | 1 |
| Gareri, P; Secades, JJ | 1 |
| Antonelli Incalzi, R; Bonvicini, M; Lelli, D; Pedone, C; Travaglini, S | 1 |
| Bakulin, DA; Kovalenko, AL; Kurkin, DV; Kuznetsova, EV; Lycheva, NA; Morkovin, EI; Myagkova, IA; Robertus, AI; Shmidt, MV; Tarasov, AS | 1 |
| Almeria, M; Alvarez, I; Arribas, S; Besora, S; Buongiorno, M; Cano, C; Casas, L; Castejon, J; Krupinski, J; Molina-Seguin, J; Romero, S | 1 |
| Guan, X; Jiang, G; Pang, T; Tang, L; Xie, L; Zhao, N; Zhu, X | 1 |
| Bokova, IA; Shavlovskaya, OA | 1 |
| Nemkova, SA; Semenov, DV; Vozvyshaeva, MY; Zavadenko, NN | 2 |
| Secades, JJ | 1 |
| Chen, S; Fisher, M; Lin, LL; Liu, BZ; Liu, CZ; Shi, GX; Sun, SF; Tan, C; Tu, JF; Wang, J; Wang, LQ; Wu, LY; Yan, CQ; Yang, BF; Yang, JW; Zhang, S; Zhang, ZJ | 1 |
| Fukunaga, K; Hishida, Y; Izumi, H; Kamimura, A; Nakazaki, E; Shinoda, Y; Watanabe, F; Yabuki, Y | 1 |
| Castagna, A; Cotroneo, AM; Fantò, F; Gareri, P; Lacava, R; Malara, A; Monteleone, F; Putignano, S; Rocca, F | 1 |
| Fedorova, YB; Gavrilova, SI; Kochkina, EG; Kozlova, DI; Nalivaeva, NN; Zhuravin, IА | 1 |
| Alvarez-Sabín, J; Jacas, C; Maisterra, O; Molina, C; Quintana, M; Santamarina, E | 1 |
| Abd El-Hamid, DH; Abdel-Rahman, MS; Abdel-Zaher, AO; Hamdy, MM | 1 |
| Fedorova, IaB; Gavrilova, SI; Kalyn, IaB; Kolykhalov, IV | 1 |
3 review(s) available for cytidine diphosphate choline and Cognitive Dysfunction
| Article | Year |
|---|---|
Citicoline: pharmacological and clinical review, 2022 update.
Topics: Brain Injuries, Traumatic; Cognitive Dysfunction; Cytidine Diphosphate Choline; Humans; Nootropic Agents; Stroke | 2022 |
Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
Topics: Alzheimer Disease; Cognition; Cognition Disorders; Cognitive Dysfunction; Cytidine Diphosphate Choline; Humans | 2023 |
Citicoline: pharmacological and clinical review, 2016 update.
Topics: Brain Injuries, Traumatic; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Progression; Humans; Nootropic Agents; Stroke | 2016 |
5 trial(s) available for cytidine diphosphate choline and Cognitive Dysfunction
| Article | Year |
|---|---|
[The effect of the use of the drug recognan (citicoline) on the state of higher mental functions in patients with mild cognitive impairment].
Topics: Adolescent; Adult; Cognition; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Nootropic Agents; Pharmaceutical Preparations; Young Adult | 2021 |
[Features of positive personality phenomena in patients with mild cognitive impairment and asthenic syndrome treated with recognan (citicoline)].
Topics: Adolescent; Adult; Asthenia; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Middle Aged; Personality; Personality Disorders; Young Adult | 2020 |
Effectiveness of acupuncture for vascular cognitive impairment no dementia: a randomized controlled trial.
Topics: Acupuncture Therapy; Aged; China; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disability Evaluation; Female; Humans; Middle Aged; Neuropsychological Tests; Nootropic Agents | 2019 |
Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
Topics: Activities of Daily Living; Administration, Oral; Aged; Aged, 80 and over; Cognitive Dysfunction; Cytidine Diphosphate Choline; Depression; Female; Folic Acid; Geriatric Assessment; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Nootropic Agents; Thyroid Hormones; Tomography, X-Ray Computed; Vascular Diseases; Vitamin B 12 | 2013 |
[Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Middle Aged; Nootropic Agents; Syndrome | 2011 |
10 other study(ies) available for cytidine diphosphate choline and Cognitive Dysfunction
| Article | Year |
|---|---|
[Citicoline in the treatment of cognitive impairment in first-degree relatives of AD patients: the influence of the ApoE genotype].
Topics: Alzheimer Disease; Apolipoproteins E; Cognitive Dysfunction; Cytidine Diphosphate Choline; Genotype; Humans; Neuropsychological Tests | 2021 |
[Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Carotid Stenosis; Cognitive Dysfunction; Constriction, Pathologic; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Nicergoline; Rats; Shock | 2023 |
Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease.
Topics: Aged; Apolipoproteins E; Cerebrovascular Disorders; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Prospective Studies; Quality of Life | 2023 |
The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
Topics: Animals; Cognitive Dysfunction; Cytidine Diphosphate Choline; Dementia, Vascular; NAD; Neuroinflammatory Diseases; Neuronal Outgrowth; Nicotinamide Mononucleotide; Rats; Sirtuin 1 | 2023 |
[Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].
Topics: Adolescent; Cognition Disorders; Cognitive Dysfunction; Cytidine Diphosphate Choline; Humans; Ischemic Stroke; Nootropic Agents | 2023 |
[The influence of the drug recognan (citicoline) on neurodynamic characteristics of mental activity in patients with mild cognitive impairment].
Topics: Adolescent; Adult; Cognition; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Middle Aged; Nootropic Agents; Pharmaceutical Preparations; Young Adult | 2021 |
Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia.
Topics: Animals; Avoidance Learning; Brain Ischemia; CA1 Region, Hippocampal; Cell Survival; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Models, Animal; Docosahexaenoic Acids; Drug Therapy, Combination; Learning; Male; Memory; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Recognition, Psychology; Treatment Outcome | 2019 |
[The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer's disease].
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Biomarkers; Butyrylcholinesterase; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Progression; Female; Humans; Male; Neprilysin; Nootropic Agents | 2015 |
Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke.
Topics: Aged; Brain Ischemia; Cognitive Dysfunction; Cytidine Diphosphate Choline; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Random Allocation; Stroke | 2016 |
Protective effect of citicoline against aluminum-induced cognitive impairments in rats.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Avoidance Learning; Behavior, Animal; Chlorides; Cognitive Dysfunction; Cytidine Diphosphate Choline; Environmental Pollutants; Glutamic Acid; Hippocampus; Injections, Intraperitoneal; Lipid Peroxidation; Male; Maze Learning; Memory, Short-Term; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide; Nootropic Agents; Oxidative Stress; Rats, Wistar | 2017 |